会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • ENHANCEMENT OF THE ACTION OF ANTI-INFECTIVE AGENTS AND OF CENTRAL AND PERIPHERAL NERVOUS SYSTEM AGENTS AND TRANSPORTATION OF NUCLEIC ACID SUBSTANCES
    • 增强抗感染药物和中枢和外周神经系统药物和运输核酸物质的作用
    • US20130336990A1
    • 2013-12-19
    • US13709596
    • 2012-12-10
    • North West University
    • Petrus Johannes MEYER
    • A61K31/7088A61K38/02C12N15/63A61K39/395
    • A61K31/7088A61K9/0019A61K9/4866A61K31/133A61K31/4409A61K31/496A61K31/4965A61K38/02A61K39/39533A61K47/02C12N15/63
    • The invention provides a method of enhancing the action of a pharmaceutical agent selected from the group consisting of the anti-infective agents, the group comprising of the antimicrobial agents, the anthelmintic agents and the anti-ectoparasitic agents, but excluding coal tar solution and H1-antagonist antihistamines, and from the group consisting of the CPNS agents selected from the group of compounds acting on the central or peripheral nervous system, but excluding coal tar solution and H1-antagonist antihistamines and also excluding anti-inflammatory, analgesic and antipyretic agents and also provides an enhanced method for the administration of a nucleic acid substance to the cells of an animal, a plant or a micro-organism. The method is characterised in that the agent or nucleic acid substance is formulated with an administration medium which comprises a solution of nitrous oxide gas in a pharmaceutically acceptable carrier solvent for the gas and which administration medium includes at least one fatty acid or ester or other suitable derivative thereof selected from the group consisting of oleic acid, linoleic acid, alpha-linolenic acid, gamma-linolenic acid, arachidonic acid, eicosapentaenoic acid [C20:5ω3], decosahexaenoic acid [C22:6ω3], ricinoleic acid and derivatives thereof selected from the group consisting of the C1 to C6 alkyl esters thereof, the glycerol-polyethylene glycol esters thereof and the reaction product of hydrogenated natural oils composed largely of ricinoleic acid based oils, such as castor oil with ethylene oxide. The formulations of such agents or substances form part of the invention
    • 本发明提供一种增强选自抗感染剂,抗微生物剂组,驱肠虫剂和抗外寄生剂组,但不包括煤焦油溶液和H1的药剂的作用的方法 - 拮抗剂抗组胺剂,以及选自选自作用于中枢或周围神经系统的化合物组,但不包括煤焦油溶液和H1-拮抗剂抗组胺剂的CPNS药剂组,并且除了消炎止痛和解热剂之外 还提供了用于向动物,植物或微生物的细胞施用核酸物质的增强的方法。 该方法的特征在于,所述试剂或核酸物质与给药培养基一起配制,所述施用培养基包含一氧化二氮气体在用于气体的药学上可接受的载体溶剂中的溶液,并且所述施用培养基包括至少一种脂肪酸或酯或其它合适的 衍生物,其选自油酸,亚油酸,α-亚麻酸,γ-亚麻酸,花生四烯酸,二十碳五烯酸[C20:5omega3],十二碳六烯酸[C22:6omega3],蓖麻油酸及其衍生物 由其C1至C6烷基酯,其甘油 - 聚乙二醇酯和主要由蓖麻油酸基油(例如蓖麻油与环氧乙烷)组成的氢化天然油的反应产物组成的组。 这些试剂或物质的制剂形成本发明的一部分
    • 10. 发明申请
    • PLANT SUPPORT FORMULATION, VEHICLE FOR THE DELIVERY AND TRANSLOCATION OF PHYTOLOGICALLY BENEFICIAL SUBSTANCES AND COMPOSITIONS CONTAINING SAME
    • 植物支持制剂,用于交付和转移生物学上有益物质的物质和包含其的组合物
    • US20140194288A1
    • 2014-07-10
    • US14206251
    • 2014-03-12
    • North-West University
    • Anne Frederica GROBLER
    • A01N37/06A01N43/653
    • A01N43/653A01N25/04A01N37/02A01N37/06A01N2300/00
    • A plant supporting formulation which is also suitable for use as a delivery vehicle, or a component of a delivery vehicle, for the delivery of one or more phytologically beneficial substances to a plant, and for enhancing the translocation of such delivered substance(s) in or on the plant, the formulation comprising a micro-emulsion constituted by a dispersion of vesicles or microsponges of a fatty acid based component in an aqueous carrier, the fatty acid based component comprising at least one long chain fatty acid based substance selected from the group consisting of free fatty acids and derivatives of free fatty acids. The dispersion is preferably characterized in that at least 50% of the vesicles or microsponges are of a diametrical size of between 50 nm and 5 micrometer. The dispersion is further also characterized in that the micro-emulsion has a zeta potential of between −25 mV and −60 mV.
    • 一种植物支持制剂,其也适用于作为递送载体或递送载体的组分,用于将一种或多种植物有益物质递送至植物,以及用于增强这些递送物质的易位 或在植物上,所述制剂包含由水性载体中脂肪酸组分的囊泡或微球分散体构成的微乳液,所述脂肪酸基组分包含至少一种长链脂肪酸基物质,所述物质选自 由游离脂肪酸和游离脂肪酸的衍生物组成。 该分散体的特征在于,至少50%的囊泡或微球的直径尺寸为50nm至5微米。 该分散体的特征还在于微乳液的ζ电位在-25mV和-60mV之间。